The Segal Institute is excited to participate in an important research study of a phase III drug that may help manage Tardive Dyskinesia (TD). By participating in this research, we…
Read More
The Segal Institute is excited to participate in an important research study of a phase III drug that may help manage Tardive Dyskinesia (TD). By participating in this research, we…